Weiss Asset Management’s Zimmer Biomet ZBH Stock Holding History

Weiss Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,077	Closed	-$325K	–	709
2024 Q4	$325K	Buy	+3,077	New	+$330K	0.01%	524
2023 Q2	–	Sell	-3,900	Closed	-$504K	–	324
2023 Q1	$504K	Buy	+3,900	New	+$490K	0.03%	207
2021 Q3	–	Sell	-8,229	Closed	-$1.28M	–	624
2021 Q2	$1.28M	Buy	+8,229	New	+$1.33M	0.03%	344

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Weiss Asset Management's ZBH Position: Q1 2025 in Review

Weiss Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 3,077 shares — an estimated $325K sold.

Weiss Asset Management first reported a position in ZBH in Q2 2021 and held it in 3 quarters. The position peaked at $1.28M in Q2 2021. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

Weiss Asset Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
Weiss Asset Management sold 3,077 Zimmer Biomet shares in Q1 2025, an estimated $325K.
Weiss Asset Management first reported a position in Zimmer Biomet in Q2 2021 and held it in 3 quarters.
Weiss Asset Management's Zimmer Biomet position peaked at $1.28M in Q2 2021.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Weiss Asset Management's 13F filing for Q1 2025, filed 15 May 2025.